Related Experiment Video
Updated: Aug 2, 2026
09:16
A General Method for Evaluating Deep Brain Stimulation Effects on Intravenous Methamphetamine Self-Administration
Published on: January 22, 2016
Survey method for post-marketing drug surveillance: a demonstration
G D Mellinger1, M B Balter, S Abramowitz
1Institute for Research in Social Behavior, Oakland, California.
Journal of Clinical Psychopharmacology
|June 1, 1988
Summary
This study piloted a community survey method for post-marketing drug monitoring, finding it accurately assessed medication outcomes. The method offers insights into drug efficacy and safety beyond clinical trials.
Area of Science:
- Pharmacovigilance
- Survey Research
- Clinical Pharmacology
Background:
- Post-marketing drug monitoring is crucial for assessing real-world medication performance.
- Existing clinical trials often exclude diverse patient populations and real-world usage conditions.
- Community surveys offer a complementary approach to evaluate drug safety and efficacy.
Purpose of the Study:
- To describe and evaluate a community survey method for post-marketing drug surveillance.
- To assess the validity of the survey method by comparing predicted and observed outcomes for specific drug classes.
- To explore the potential of this method for evaluating drug efficacy and safety in routine clinical practice.
Main Methods:
- A pilot study employed a community survey method with representative outpatient samples.
- Patients receiving tricyclic antidepressants or benzodiazepine anxiolytics were interviewed at baseline and intervals.
- Data collection utilized trained lay interviewers and a detailed schedule informed by expert input.
Main Results:
- The survey method accurately predicted observed outcomes for the studied drug classes.
- Results precisely matched expectations regarding symptom changes and medication effects.
- The method demonstrated validity in assessing drug effects in a community setting.
Conclusions:
- The community survey method is a valuable tool for post-marketing drug monitoring, assessing both efficacy and safety.
- This approach provides insights into drug performance under real-world conditions, complementing clinical trial data.
- Valuable data on prescribing patterns and patient usage can be generated, informing professional education and product liability.
More Related Videos
10:17High-throughput and Comprehensive Drug Surveillance Using Multisegment Injection-Capillary Electrophoresis-Mass Spectrometry
Published on: April 23, 2019
07:05Correlative Optical Spectroscopy and Mass Spectrometry Imaging Methodology to Visualise Drug Distribution in a Soft Tissue Section
Published on: June 20, 2025
Related Concept Videos
02:16Surveys
Often, psychologists develop surveys as a means of gathering data. Surveys are lists of questions to be answered by research participants, and can be delivered as paper-and-pencil questionnaires, administered electronically, or conducted verbally. Generally, the survey itself can be completed in a short time, and the ease of administering a survey makes it easy to collect data from a large number of people.
01:07Data Collection by Survey
The systematic method of obtaining and analyzing accurate information of a population is called data collection. A survey is a standard method of data collection that involves collecting information from a target human population about their experience, opinion, or knowledge of a product, service, or process. The responses are recorded and interpreted. The most common survey examples are written questionnaires, face-to-face or telephonic conversations, focus groups, and electronic (e-mail or...
01:16Clinical Trials
Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
There are four phases in a clinical trial. A phase one...
01:11Clinical Trials: Overview
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
01:12Analysis of Population Pharmacokinetic Data
Analysis of population pharmacokinetic data involves studying the behavior of drugs within diverse populations to understand their pharmacokinetic parameters. Traditional pharmacokinetic methods typically involve collecting samples from a few individuals and estimating these parameters. While these methods are commonly used, they have limitations in capturing the variability in drug response among individuals or heterogeneous populations. Population pharmacokinetics is employed to address these...
01:26Therapeutic Drug Monitoring: Drug Analysis Methods
Therapeutic Drug Monitoring (TDM) is a clinical practice that measures specific drug levels in a patient's blood or body tissues to tailor drug therapy effectively. This monitoring is critical for managing drugs with narrow therapeutic indices like digoxin and phenytoin, ensuring they are both safe and effective. For instance, monitoring theophylline levels in asthma patients involves precision and sensitivity to adjust doses according to individual responses to therapy, ensuring efficacy and...